Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
The NHS Commissioning Board (Operating Under the Name of NHS England)
2nd Floor, Rutland House
Runcorn
WA7 2ES
UK
E-mail: michelle.clarke6@nhs.net
NUTS: UK
Internet address(es)
Main address: https://nhsengland.bravosolution.co.uk
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.4) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
NHS Framework for the NHS South of England, Branded Medicines – Tranche A, Cytokine Modulators and Other Monoclonal Antibodies, and Antiretrovirals for Midlands and East and North of England
Reference number: CM/PHR/16/5521
II.1.2) Main CPV code
33600000
II.1.3) Type of contract
Supplies
II.1.4) Short description
Offer reference number: CM/PHR/16/5521
CM/PHR/16/5521/01 — NHS Framework for the NHS South of England, Branded Medicines – tranche A, period of framework: 1.9.2019 to 31.8.2021 with an option to extend (at the authority’s discretion) for a period or periods up to a total of 24 months
CM/PHR/16/5521/02 — NHS Framework for the NHS South of England, Branded Medicines – annual tranche — cytokine modulators and other monoclonal antibodies, period of framework: 1.9.2019 to 31.8.2020 with an option to extend (at the authority’s discretion) for a period or periods up to a total of 12 months.
CM/PHR/16/5521/03 — NHS Framework Agreement for Proprietary Pharmaceuticals Interim 2019 – Midlands and East and North of England, period of framework agreement: Midlands and East 1.9.2019 to 29.2.2020: North of England 1.9.2019 to 28.2.2021.
II.1.6) Information about lots
This contract is divided into lots:
Yes
II.1.7) Total value of the procurement
Value excluding VAT:
376 009 922.00
GBP
II.2) Description
Lot No: 1
II.2.1) Title
CM/PHR/16/5521/01 — NHS Framework for the NHS South of England, Branded Medicines – Tranche A
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UKJ
UKK
Main site or place of performance:
Please refer to document 03 schedule 8 in the ITO documents for the list of purchasing points.
II.2.4) Description of the procurement
CM/PHR/16/5521/01 — NHS Framework for the NHS South of England, Branded Medicines – tranche A, period of framework: 1.9.2019 to 31.8.2021 with an option to extend (at the authority’s discretion) for a period or periods up to a total of 24 months.
II.2.5) Award criteria
Quality criterion: Price is not the only award criterion and all criteria are stated only in the procurement documents
/ Weighting: n/a
Cost criterion: Price is not the only award criterion and all criteria are stated only in the procurement documents
/ Weighting: n/a
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 2
II.2.1) Title
CM/PHR/16/5521/02 — NHS Framework for the NHS South of England, Branded Medicines – Annual Tranche — Cytokine Modulators and Other Monoclonal Antibodies
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UKC
UKD
UKE
UKF
UKG
UKH
UKI
UKJ
UKK
Main site or place of performance:
Please refer to document 03 schedule 8 in the ITO documents for the list of purchasing points.
II.2.4) Description of the procurement
CM/PHR/16/5521/02 — NHS Framework for the NHS South of England, Branded Medicines – annual tranche — cytokine modulators and other monoclonal antibodies, period of framework: 1.9.2019 to 31.8.2020 with an option to extend (at the authority’s discretion) for a period or periods up to a total of 12 months.
II.2.5) Award criteria
Quality criterion: Price is not the only award criterion and all criteria are stated only in the procurement documents
/ Weighting: n/a
Cost criterion: rice is not the only award criterion and all criteria are stated only in the procurement documents
/ Weighting: n/a
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 3
II.2.1) Title
CM/PHR/16/5521/03 — NHS Framework Agreement for Proprietary Pharmaceuticals Interim 2019 — Midlands and East and North of England
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UKC
UKD
UKF
UKG
UKH
Main site or place of performance:
Please refer to document 03 schedule 8 in the ITO documents for the list of purchasing points.
II.2.4) Description of the procurement
CM/PHR/16/5521/03 — NHS Framework Agreement for Proprietary Pharmaceuticals Interim 2019 — Midlands and East and North of England, period of framework agreement: Midlands and East 1.9.2019 to 29.2.2020: North of England 1.9.2019 to 28.2.2021.
II.2.5) Award criteria
Quality criterion: Price is not the only award criterion and all criteria are stated only in the procurement documents
/ Weighting: n/a
Cost criterion: Price is not the only award criterion and all criteria are stated only in the procurement documents
/ Weighting: n/a
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.3) Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2019/S 053-121251
Section V: Award of contract
Contract No: CM/PHR/16/5521
Title: NHS Framework for the NHS South of England, Branded Medicines – Tranche A
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
01/08/2019
V.2.2) Information about tenders
Number of tenders received: 23
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
The NHS Commissioning Board (Operating Under the Name of NHS England)
Runcorn
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 173 754 620.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Contract No: CM/PHR/16/5521/02
Title: NHS Framework for the NHS South of England, Branded Medicines – Annual Tranche — Cytokine Modulators and Other Monoclonal Antibodies
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
01/08/2019
V.2.2) Information about tenders
Number of tenders received: 12
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
The NHS Commissioning Board (Operating Under the Name of NHS England)
Runcorn
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 202 255 302.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: 3
Contract No: CM/PHR/16/5521/03
Title: NHS Framework Agreement for Proprietary Pharmaceuticals Interim 2019 — Midlands and East and North of England
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
01/08/2019
V.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
The NHS Commissioning Board (Operating Under the Name of NHS England)
Runcorn
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.4) Procedures for review
VI.4.1) Review body
The Royal Courts of Justice
London or any of the district registry of the High Court
UK
VI.5) Date of dispatch of this notice
14/10/2019